Newtyn Management’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,771
| Closed | -$252K | – | 41 |
|
|
2024
Q2 | $252K | Sell |
28,771
-19,229
| -40% | -$168K | 0.05% | 39 |
|
|
2024
Q1 | $1.18M | Sell |
48,000
-2,200
| -4% | -$53.9K | 0.23% | 36 |
|
|
2023
Q4 | $833K | Buy |
50,200
+13,400
| +36% | +$222K | 0.16% | 39 |
|
|
2023
Q3 | $687K | Buy |
36,800
+800
| +2% | +$14.9K | 0.17% | 40 |
|
|
2023
Q2 | $874K | Sell |
36,000
-4,858
| -12% | -$118K | 0.21% | 37 |
|
|
2023
Q1 | $893K | Sell |
40,858
-19,142
| -32% | -$418K | 0.18% | 60 |
|
|
2022
Q4 | $1.43M | Buy |
60,000
+20,000
| +50% | +$476K | 0.3% | 44 |
|
|
2022
Q3 | $1.1M | Buy |
40,000
+1,516
| +4% | +$41.7K | 0.24% | 50 |
|
|
2022
Q2 | $1.16M | Buy |
+38,484
| New | +$1.16M | 0.22% | 58 |
|